Test Price
2,800 AED✅ Home Collection Available
ADGRG1 Gene Polymicrogyria Bilateral Frontoparietal Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ADGRG1 لتعدد التلافيف الصدغي الثنائي الجبهي الجداري بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview
The ADGRG1 Gene Polymicrogyria Bilateral Frontoparietal Genetic Test uses Genetic Test is intended for patients with clinical or radiological suspicion, enabling precise diagnosis, genetic counselling, and informed clinical management under DHA‑approved protocols.
| Feature | Our ADGRG1 NGS Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Diagnostic Precision | >99.9% sensitivity for ADGRG1 targeted region, deep coverage (>100×) | ~98% sensitivity; may miss intronic ADGRG1 variants |
| Methodology | NGS panel with proprietary enrichment, clinically validated | Non-specific capture; incidental findings burden |
| Turnaround Time | 3 to 4 Weeks (expedited reporting available) | 4 to 6 Weeks |
| Price (AED) | 2,800 (insurance eligible) | 3,000–5,000 (often not covered for isolated malformation) |
Physician Insight & Safety Protocol
“As a clinical geneticist, I must stress that a positive ADGRG1 result is not a standalone diagnosis; it must always be correlated with MRI findings and the clinical phenotype of bilateral frontoparietal polymicrogyria. My team and I are committed to guiding you through this sensitive process with the utmost empathy, ensuring every result is explained, and that further family testing or reproductive options are discussed compassionately.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace acute neurological management.
Safety Exclusion Criteria
- Not suitable for individuals without a clinical or imaging suspicion of frontoparietal polymicrogyria.
- Cannot be performed on patients unable or unwilling to provide informed consent (guardian consent mandatory for minors).
- This is an elective genetic test; acute emergencies must be managed in an ER setting.
Emergency Red Flags (Seek Immediate Care)
- Uncontrolled seizures or status epilepticus
- Apnoea, severe respiratory distress, or altered consciousness
- Sudden loss of developmental milestones
- Signs of raised intracranial pressure
Pre-Test Requirements
A clinical history and a genetic counselling session (including drawing a detailed pedigree chart of family members affected by polymicrogyria or related neurodevelopmental conditions) are mandatory prior to sample collection. The test requires a blood sample collected in a DNA FTA card.
Patient FAQ & Clinical Guidance
Q: What exactly does the ADGRG1 gene test look for, and how accurate is it?
Answer: This test sequences the entire coding region of the ADGRG1 gene to detect pathogenic variants, achieving a diagnostic sensitivity exceeding 99.9% in clinically suspected polymicrogyria. It can identify single nucleotide variants, small insertions/deletions, and copy number changes that disrupt normal cortical development. All variants are classified according to ACMG guidelines by our DHA-licensed molecular geneticists.
جواب: يقوم هذا الفحص بتسلسل المنطقة التشفيرية الكاملة لجين ADGRG1 لكشف الطفرات المرضية بدقة تشخيصية تتجاوز 99.9% لدى المرضى المحتمل إصابتهم بتعدد التلافيف الصدغي. يحدد الفحص التغيرات النيوكلوتيدية المفردة والإدخالات/الحذف الصغيرة وتغيرات عدد النسخ التي تعطّل تطور القشرة الدماغية، وتُصنف جميع الطفرات وفق معايير ACMG من قبل فريقنا الحائز على رخصة هيئة الصحة بدبي.
Q: How long until I receive my results, and will a doctor explain them to me?
Answer: Your report will be finalised within 3 to 4 weeks, and a complimentary telephonic consultation with a clinical geneticist is provided to translate the findings. We walk you through every detail, including inheritance patterns, recurrence risk for future pregnancies, and any necessary referrals to paediatric neurology or neurosurgery.
جواب: تكتمل النتيجة خلال 3 إلى 4 أسابيع، وستحصل على استشارة هاتفية مجانية مع استشاري أمراض وراثية لتفسير النتائج. نشرح لك بالتفصيل نمط الوراثة، احتمالية تكرار المرض في الأحمال القادمة، وضرورة التحويل إلى طب أعصاب الأطفال أو جراحة الأعصاب إن لزم الأمر.
Q: Is this test approved by UAE health authorities and covered by insurance?
Answer: Yes, the test is performed in a ISO 9001:2015 certified facility licensed by DHA and MOHAP, and most major UAE insurers reimburse the when pre-authorised. We handle direct billing verification via WhatsApp at +971545488731, ensuring a seamless claims process under Federal Law No. 41 of 2024 and CDS Law provisions for minors.
جواب: نعم، يُجرى الفحص في منشأة حاصلة على شهادة ISO 9001:2015 ومرخصة من هيئة الصحة بدبي ووزارة الصحة، وتغطي معظم شركات التأمين الكبرى التكلفة بعد الحصول على موافقة مسبقة. نقدم خدمة التحقق من الفوترة عبر واتساب على الرقم +971545488731 بما يتوافق مع أحكام القانون الاتحادي رقم 41 لسنة 2024 وقانون حماية بيانات القاصرين.
Licensed by DHA/MOHAP Facility License: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
All services strictly adhere to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 for Minors, and UAE PDPL for personal data protection.
LOINC: 98066-7 (loinc.org/98066-7). ICD-10-CM: Q04.3, Z13.71, Z14.8.
NGS methodology, sample type: Blood on DNA FTA card. TAT: 3–4 Weeks.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians